Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts.

PubWeight™: 2.24‹?› | Rank: Top 2%

🔗 View Article (PMID 7671375)

Published in Circulation on October 01, 1995

Authors

R M Judd1, C H Lugo-Olivieri, M Arai, T Kondo, P Croisille, J A Lima, V Mohan, L C Becker, E A Zerhouni

Author Affiliations

1: Department of Radiology, Johns Hopkins University, Baltimore, Md 21287, USA.

Associated clinical trials:

POSTconditioning During Coronary Angioplasty in Acute Myocardial Infarction Study (POST-AMI) | NCT01004289

Articles citing this

Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation (2007) 5.09

Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol (2011) 3.74

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33

Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation (2006) 2.07

Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96

Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging. J Am Coll Cardiol (2006) 1.89

Distinction of salvaged and infarcted myocardium within the ischaemic area-at-risk with T2 mapping. Eur Heart J Cardiovasc Imaging (2014) 1.57

ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis. Circ Arrhythm Electrophysiol (2008) 1.55

Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation. J Am Coll Cardiol (2011) 1.53

Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging. Delayed enhancement and routine clinical parameters after myocardial infarction. Int J Cardiovasc Imaging (2003) 1.44

Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart (2001) 1.38

CMR of microvascular obstruction and hemorrhage in myocardial infarction. J Cardiovasc Magn Reson (2012) 1.33

Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials. J Cardiovasc Magn Reson (2012) 1.18

Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson (2009) 1.16

Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation (2009) 1.08

Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev (2013) 1.07

Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy. Ann Neurol (2014) 1.02

Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.00

Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction. Eur Radiol (2006) 0.99

Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart (2007) 0.98

Rapid and accurate determination of relative infarct size in humans using contrast-enhanced magnetic resonance imaging. Clin Res Cardiol (2009) 0.92

Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction. Eur Radiol (2006) 0.91

Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance. Eur Heart J (2011) 0.89

Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside. Eur Radiol (2006) 0.89

Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. Eur Radiol (2009) 0.89

Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI. Cardiovasc Diagn Ther (2012) 0.88

Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction. Eur Radiol (2009) 0.88

Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol (2009) 0.87

Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol (2010) 0.87

Percent infarct mapping for delayed contrast enhancement magnetic resonance imaging to quantify myocardial viability by Gd(DTPA). J Magn Reson Imaging (2010) 0.86

Dual manganese-enhanced and delayed gadolinium-enhanced MRI detects myocardial border zone injury in a pig ischemia-reperfusion model. Circ Cardiovasc Imaging (2011) 0.85

Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease. Heart (2005) 0.84

Evaluation of the microcirculation: advances in cardiac magnetic resonance perfusion imaging. J Nucl Cardiol (2008) 0.84

Cardiac magnetic resonance imaging in stable ischaemic heart disease. Neth Heart J (2011) 0.84

MRI manifestations of persistent microvascular obstruction and acute left ventricular remodeling in an experimental reperfused myocardial infarction. Quant Imaging Med Surg (2012) 0.83

Advances in Cardiovascular MRI for Diagnostics: Applications in Coronary Artery Disease and Cardiomyopathies. Expert Opin Med Diagn (2009) 0.83

Evaluating the left atrium by magnetic resonance imaging. Europace (2008) 0.83

Late-phase MSCT in the different stages of myocardial infarction: animal experiments. Eur Radiol (2007) 0.83

Diagnostic and imaging considerations: role of viability. Heart Fail Rev (2006) 0.82

Pathological mechanism for delayed hyperenhancement of chronic scarred myocardium in contrast agent enhanced magnetic resonance imaging. PLoS One (2014) 0.82

Imaging microvascular obstruction and its clinical significance following acute myocardial infarction. Heart Fail Rev (2006) 0.81

Evaluation by contrast-enhanced MR imaging of the lateral border zone in reperfused myocardial infarction in a cat model. Korean J Radiol (2001) 0.81

Collateral circulation formation determines the characteristic profiles of contrast-enhanced MRI in the infarcted myocardium of pigs. Acta Pharmacol Sin (2015) 0.80

Right atrial hemangioma in modern cardiac imaging. Clin Res Cardiol (2006) 0.80

Salvage assessment with cardiac MRI following acute myocardial infarction underestimates potential for recovery of systolic strain. Eur Radiol (2012) 0.80

The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease. Int J Cardiovasc Imaging (2013) 0.80

Contrast-enhanced magnetic resonance imaging reveals early decrease of transmural extent of reperfused acute myocardial infarction. Clin Res Cardiol (2008) 0.80

Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine. Eur Radiol (2012) 0.79

P846, a new gadolinium based low diffusion magnetic resonance contrast agent, in characterizing occlusive infarcts, reperfused ischemic myocardium and reperfused infarcts in rats. MAGMA (2008) 0.79

Intramyocardial hemorrhage: an enigma for cardiac MRI? Biomed Res Int (2015) 0.78

Magnetic resonance imaging in the assessment of ventricular remodeling and viability. Curr Heart Fail Rep (2008) 0.78

Ventricular longitudinal function is associated with microvascular obstruction and intramyocardial haemorrhage. Open Heart (2016) 0.77

Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study. Int J Cardiovasc Imaging (2011) 0.77

Volumetric late gadolinium-enhanced myocardial imaging with retrospective inversion time selection. J Magn Reson Imaging (2013) 0.77

Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction. J Cardiovasc Magn Reson (2008) 0.77

Cardiac MR for the assessment of myocardial viability. Methodist Debakey Cardiovasc J (2013) 0.77

Cardiovascular nuclear magnetic resonance: basic and clinical applications. J Clin Invest (2003) 0.77

MPnRAGE: A technique to simultaneously acquire hundreds of differently contrasted MPRAGE images with applications to quantitative T1 mapping. Magn Reson Med (2015) 0.77

The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction. Int J Cardiovasc Imaging (2001) 0.77

Diagnostic usefulness of the oedema-infarct ratio to differentiate acute from chronic myocardial damage using magnetic resonance imaging. Eur Radiol (2011) 0.76

The microvasculature after reperfused myocardial infarction: to examine or not to examine? J Am Heart Assoc (2012) 0.76

Clinical assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA. MAGMA (2000) 0.76

Role of cardiovascular magnetic resonance in acute coronary syndrome. Glob Cardiol Sci Pract (2015) 0.75

Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and prevention. Scientifica (Cairo) (2013) 0.75

Microvascular Obstruction Evaluation Using Cardiovascular Magnetic Resonance (CMR) in ST-Elevated Myocardial Infarction (STEMI) Patients. Pol J Radiol (2015) 0.75

The significance of perfusion defect at myocardial perfusion MR imaging in a cat model of acute reperfused myocardial infarction. Korean J Radiol (2003) 0.75

CT imaging of myocardial viability: experimental and clinical evidence. Cardiovasc J Afr (2007) 0.75

Apelin-13 infusion salvages the peri-infarct region to preserve cardiac function after severe myocardial injury. Int J Cardiol (2016) 0.75

In vivo assessment of myocardial viability after acute myocardial infarction: A head-to-head comparison of the perfusable tissue index by PET and delayed contrast-enhanced CMR. J Nucl Cardiol (2016) 0.75

Early Gadolinium Enhancement for Determination of Area at Risk: A Preclinical Validation Study. JACC Cardiovasc Imaging (2016) 0.75

Determining microvascular obstruction and infarct size with steady-state free precession imaging cardiac MRI. PLoS One (2015) 0.75

Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J Cardiol (2014) 0.75

Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction. World J Cardiol (2017) 0.75

Magnetic resonance imaging and radiofrequency ablations. Herzschrittmacherther Elektrophysiol (2007) 0.75

New and revisited approaches to preserving the reperfused myocardium. Nat Rev Cardiol (2017) 0.75

Comparison between visual grading and planimetric quantification of microvascular obstruction extent assessment in reperfused acute myocardial infarction. Eur Radiol (2015) 0.75

Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging. Heart Vessels (2015) 0.75

Articles by these authors

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32

Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76

Expression of a gene cluster kaiABC as a circadian feedback process in cyanobacteria. Science (1998) 7.38

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83

High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia (2001) 5.79

Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia (2011) 5.62

Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation (1998) 4.54

Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol (1996) 4.06

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med (2000) 3.98

Circadian orchestration of gene expression in cyanobacteria. Genes Dev (1995) 3.95

Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula. Aliment Pharmacol Ther (2012) 3.91

Resonating circadian clocks enhance fitness in cyanobacteria. Proc Natl Acad Sci U S A (1998) 3.84

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med (1996) 3.72

Epidemiology and causation of coronary heart disease and stroke in India. Heart (2008) 3.60

Awareness and knowledge of diabetes in Chennai--the Chennai Urban Rural Epidemiology Study [CURES-9]. J Assoc Physicians India (2005) 3.46

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41

Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology (1996) 3.39

Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol (1998) 3.39

A kaiC-interacting sensory histidine kinase, SasA, necessary to sustain robust circadian oscillation in cyanobacteria. Cell (2000) 3.31

Nucleotide binding and autophosphorylation of the clock protein KaiC as a circadian timing process of cyanobacteria. Proc Natl Acad Sci U S A (2000) 3.17

Physical interactions among circadian clock proteins KaiA, KaiB and KaiC in cyanobacteria. EMBO J (1999) 2.97

Is the 'rule of halves' in hypertension still valid?--Evidence from the Chennai Urban Population Study. J Assoc Physicians India (2003) 2.86

M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol (2001) 2.81

Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation (1996) 2.70

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med (1990) 2.67

Mechanism of action of globomycin. J Antibiot (Tokyo) (1978) 2.66

Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet (1995) 2.65

Circadian oscillations of cytosolic and chloroplastic free calcium in plants. Science (1995) 2.63

Three-dimensional systolic strain patterns in the normal human left ventricle: characterization with tagged MR imaging. Radiology (2000) 2.63

Noninvasive measurement of transmural gradients in myocardial strain with MR imaging. Radiology (1991) 2.58

The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I). J Assoc Physicians India (2003) 2.50

CikA, a bacteriophytochrome that resets the cyanobacterial circadian clock. Science (2000) 2.50

The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy. Anesth Analg (1999) 2.42

Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer (1982) 2.39

Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci (1998) 2.39

Three-dimensional myocardial deformations: calculation with displacement field fitting to tagged MR images. Radiology (1995) 2.38

Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology (1998) 2.37

Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation (1998) 2.30

Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol (1989) 2.28

Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation (1995) 2.27

The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes. Indian J Med Res (2011) 2.26

Appearing and disappearing CT scan abnormalities and seizures. J Neurol Neurosurg Psychiatry (1985) 2.26

Circadian clocks in prokaryotes. Mol Microbiol (1996) 2.25

Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev (2007) 2.24

Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem (1999) 2.21

Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care (2003) 2.18

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med (1997) 2.17

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med (1991) 2.17

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett (1994) 2.17

Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet (1999) 2.14

Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology (1990) 2.13

Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A (1999) 2.13

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11

Pie1, a protein interacting with Mec1, controls cell growth and checkpoint responses in Saccharomyces cerevisiae. Mol Cell Biol (2001) 2.09

Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. Circulation (2000) 2.08

Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res (1971) 2.05

Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol (1991) 2.05

Cystic fibrosis in one family. J Assoc Physicians India (1993) 2.04

Postprandial hyperglycaemia--the real challenge in diabetes. J Assoc Physicians India (2001) 2.02

Of fingers, toes and penises. Nature (1997) 2.00

A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta (1985) 1.99

Calculation of three-dimensional left ventricular strains from biplanar tagged MR images. J Magn Reson Imaging (1992) 1.98

CT of the solitary pulmonary nodule. AJR Am J Roentgenol (1980) 1.98

Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ (2005) 1.98

CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology (1991) 1.94

Two-dimensional electron gas with universal subbands at the surface of SrTiO(3). Nature (2011) 1.94

High prevalence of diabetes in an urban population in south India. BMJ (1988) 1.90

Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation (1986) 1.88

Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye (Lond) (2005) 1.83

The dynamics of interactions between Plasmodium and the mosquito: a study of the infectivity of Plasmodium berghei and Plasmodium gallinaceum, and their transmission by Anopheles stephensi, Anopheles gambiae and Aedes aegypti. Int J Parasitol (2003) 1.82

A patient with overlapping Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and Guillain-Barré syndrome during the clinical course. Eur J Neurol (2002) 1.81

Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol (1985) (1995) 1.81

Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res (1979) 1.81

Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation (1998) 1.80

Computed tomography of the pulmonary parenchyma. Part 2: Interstitial disease. J Thorac Imaging (1985) 1.80

Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation (1984) 1.79

Targeted inversion of a polar silencer within the HoxD complex re-allocates domains of enhancer sharing. Nat Genet (2000) 1.78

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron (1994) 1.77

Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr (1994) 1.76

Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem (2001) 1.76

Solitary pulmonary nodules: CT assessment. Radiology (1986) 1.76

Noninvasive quantification of left ventricular rotational deformation in normal humans using magnetic resonance imaging myocardial tagging. Circulation (1990) 1.74

Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. J Am Coll Cardiol (1999) 1.69

The changing scenario of the diabetes epidemic: implications for India. Indian J Med Res (2002) 1.68

Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol (1985) (1995) 1.68

Profilin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci U S A (2001) 1.68

Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation (1989) 1.68

Two KaiA-binding domains of cyanobacterial circadian clock protein KaiC. FEBS Lett (2001) 1.67

Free radical formation induced by ultrasound and its biological implications. Free Radic Biol Med (1992) 1.67

Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation (1990) 1.66

High resolution intravascular MRI and MRS by using a catheter receiver coil. Magn Reson Med (1996) 1.66

The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med (1990) 1.66

Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation (1998) 1.65

Myocardial tagging in polar coordinates with use of striped tags. Radiology (1990) 1.64